Aggrelyte-2 promotes protein solubility and decreases lens stiffness through lysine acetylation and disulfide reduction: Implications for treating presbyopia.

The WS content was 13.2% higher ( p < 0.01) in the aggrelyte‐2‐treated human lenses than in the untreated controls (contralateral lenses, Figure 4i ), but the difference (4.6% higher) did not reach statistical significance when compared to the aggrelyte‐2C‐treated lenses.

also in 111,027 other papers